_participant-1-prof-lucia-altucci-md-phd.jpg "Participant 1: Prof. Lucia ALTUCCI, MD, PhD from erythroid Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 32 sec
✓ Published: 22-Oct-2010
✓ Published: 22-Oct-2010
Description:
Participant 1: Prof. Lucia ALTUCCI, MD, PhDnnDepartment of General Pathology, Seconda Università degli Studi di Napoli, ItalynDescription of the contribution to the projectnnCO1 group will evaluate the settings of global LChIP and sorting LChIP (WP1, 3, 4). Dynamic chromatin regulations in terms of TFs occupancies (Sps, MYC family etc), phosphorylation, acetylation and methylation, will be globally analysed. LChIP and global LChIP studies will be performed to compare XChIP with the LChIP techno
Participant 1: Prof. Lucia ALTUCCI, MD, PhDnnDepartment of General Pathology, Seconda Università degli Studi di Napoli, ItalynDescription of the contribution to the projectnnCO1 group will evaluate the settings of global LChIP and sorting LChIP (WP1, 3, 4). Dynamic chromatin regulations in terms of TFs occupancies (Sps, MYC family etc), phosphorylation, acetylation and methylation, will be globally analysed. LChIP and global LChIP studies will be performed to compare XChIP with the LChIP techno
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_evaluating-erythroid-precursors-in-patients-with-lr-mds-to-predict-response-to-esas.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
⏲ 1 minute 49 seconds 👁 31
_erythroid-and-megakaryoblastic-leukemia-from-models-to-targeted-therapy.webp "UW Video")
⏲ 54 minutes 20 seconds 👁 342
_pure-erythroid-leukaemias.webp "Dr Montalbán Bravo meets with ecancertv at ASH 2016 to discuss the aetiology and prognostic outlook of pure erythroid leukaemia, a subset of acute leukaemia.nnHe discusses the cell lineage of the disease, and describes sequencing data helping to form a greater genetic and biological understanding of PEL and its treatment choices.nnDr Montalbán Bravo also spoke with ecancer about the clinical utility of guadecitabine and azacitadine plus verinostat.")
_morphology-of-erythroid-cells.webp "Blood and Hematology")
_evaluating-erythroid-precursors-in-patients-with-lr-mds-to-predict-response-to-esas.jpg)
_erythroid-and-megakaryoblastic-leukemia-from-models-to-targeted-therapy.jpg)
_pure-erythroid-leukaemias.jpg)
_morphology-of-erythroid-cells.jpg)
![[+]](/images/menu.gif){kind=small}